Yang Zhuying, Xia Liang
Department of Gastroenterology, Tongde Hospital of Zhejiang Province, Hangzhou, China.
J Gastrointest Oncol. 2022 Jun;13(3):985-996. doi: 10.21037/jgo-22-307.
We aimed to study the effects and potential mechanism of resveratrol (RS) in gastric cancer (GC).
The human GC cell line SGC7901 was treated with different concentrations of RS (0, 1, 5 µM) for 24 hours. The messenger ribonucleic acid or protein expressions levels of metastasis-associated lung adenocarcinoma transcript 1 (), micro ribonucleic acid-383-5p (), and DNA damage-inducible transcript 4 (DDIT4) in GC cells were determined by Western blot and quantitative real-time polymerase chain assays. Cells were then transfected with miR-383-5p inhibitor (inhibitor), inhibitor negative control (NC), -interfering RNA (si-), si- and negative interference control (si-NC). The Cell Counting Kit-8 method, scratch assay, and transwell assay were performed to evaluate cell proliferation, migration, and invasion. Additionally, flow cytometry was used to examine apoptosis, and the target relationship was examined by a luciferase-reporter gene analysis.
RS treatment downregulated the expression of , repressed cell proliferation, inhibited cell migration and invasion (all P<0.05), and induced apoptosis (P<0.05) in GC cells. When the cells were treated with RS and inhibited the expression of meanwhile, the above anti-cancer effects were more significant (all P<0.05). Target prediction and the luciferase-reporter gene analysis showed that targeted (P<0.05). When suppressing the expression of and , the anti-cancer effects caused by the silencing of were absent (all P<0.05). We also found that miR-383-5p targeted protein. When the expression of and in the GC cells was inhibited, the promoting cancer effects caused by the inhibition of were reversed (all P<0.05).
This study found that RS inhibited the proliferation, migration, and invasion of human GC cells through the metastasis-associated lung adenocarcinoma transcript 1 ()/ pathway and induced apoptosis.
我们旨在研究白藜芦醇(RS)对胃癌(GC)的影响及其潜在机制。
用不同浓度的RS(0、1、5 μM)处理人胃癌细胞系SGC7901 24小时。通过蛋白质免疫印迹法和定量实时聚合酶链反应测定胃癌细胞中转移相关肺腺癌转录本1()、微小核糖核酸-383-5p()和DNA损伤诱导转录本4(DDIT4)的信使核糖核酸或蛋白质表达水平。然后用miR-383-5p抑制剂(抑制剂)、抑制剂阴性对照(NC)、-干扰RNA(si-)、si-和阴性干扰对照(si-NC)转染细胞。采用细胞计数试剂盒-8法、划痕试验和Transwell试验评估细胞增殖、迁移和侵袭。此外,用流式细胞术检测细胞凋亡,并通过荧光素酶报告基因分析检测靶标关系。
RS处理下调了的表达,抑制了胃癌细胞的增殖、迁移和侵袭(均P<0.05),并诱导细胞凋亡(P<0.05)。当细胞用RS处理并同时抑制的表达时,上述抗癌作用更显著(均P<0.05)。靶标预测和荧光素酶报告基因分析表明靶向(P<0.05)。当抑制和的表达时,沉默所引起的抗癌作用消失(均P<0.05)。我们还发现miR-383-5p靶向蛋白。当胃癌细胞中和的表达被抑制时,抑制所引起的促癌作用被逆转(均P<0.05)。
本研究发现RS通过转移相关肺腺癌转录本1()/途径抑制人胃癌细胞的增殖、迁移和侵袭并诱导细胞凋亡。